Literature DB >> 11139963

Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease.

M Martinelli Filho1, S F De Siqueira, H Moreira, A Fagundes, A Pedrosa, S D Nishioka, R Costa, M Scanavacca, A D'Avila, E Sosa.   

Abstract

The implantable cardioverter defibrillator (ICD) is highly effective in the treatment of ventricular arrhythmias (VA) responsible for sudden cardiac death. However, the probability of occurrence of these arrhythmic events in presence of cardiomyopathy remains uncertain. The aim of this study was to compare the probability of nonoccurrence of life-threatening VA in ICD recipients with Chagas' versus non-Chagas' heart disease. Over a mean follow-up of 10.5 months, 53 ICD recipients (mean age = 50.1 years, 48 male) were evaluated. Eleven patients had Chagas' heart disease, 19 had idiopathic dilated cardiomyopathy and 23 had ischemic cardiomyopathy. Ventricular tachyarrhythmias with a cycle length < 315 ms were considered life-threatening. The cumulative probability of nonoccurrence of life-threatening VA was examined by Kaplan-Meyer method and the outcomes were submitted to the log rank test. At 2 years, the cumulative probability of life-threatening VA nonoccurrence was 0 in the Chagas' heart disease group versus 40% up to 55 months of follow-up in the non-Chagas' disease group (P = 0.0097). Among patients with cardiomyopathies of different etiologies, those with Chagas' heart disease had the lowest cumulative probability of nonoccurrence of life-threatening VA, confirming its unfavorable prognosis and the importance of preventive measures against sudden death in this disease.

Entities:  

Mesh:

Year:  2000        PMID: 11139963     DOI: 10.1111/j.1540-8159.2000.tb07058.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

2.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

Review 3.  Chagas Cardiomyopathy in Latin America Review.

Authors:  Jefferson Luis Vieira; Fábio Rocha Fernandes Távora; Maria Gyslane Vasconcelos Sobral; Glauber Gean Vasconcelos; Germana Porto Linhares Almeida; Juliana Rolim Fernandes; Laura Leite da Escóssia Marinho; Daniel Francisco de Mendonça Trompieri; João David De Souza Neto; Juan Alberto Cosquillo Mejia
Journal:  Curr Cardiol Rep       Date:  2019-02-12       Impact factor: 3.955

4.  Evidence of reversible bradycardia and arrhythmias caused by immunogenic proteins secreted by T. cruzi in isolated rat hearts.

Authors:  Héctor O Rodríguez-Angulo; Jhoan Toro-Mendoza; Juan A Marques; Juan L Concepción; Rafael Bonfante-Cabarcas; Yoliver Higuerey; Luz E Thomas; Leandro Balzano-Nogueira; José R López; Alfredo Mijares
Journal:  PLoS Negl Trop Dis       Date:  2015-02-03

5.  Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients.

Authors:  Francisca Tatiana Moreira Pereira; Eduardo Arrais Rocha; Marcelo de Paula Martins Monteiro; Neiberg de Alcantara Lima; Carlos Roberto Martins Rodrigues Sobrinho; Roberto da Justa Pires Neto
Journal:  Arq Bras Cardiol       Date:  2016-07-11       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.